Why the creator economy is a profound threat to advertising agencies
Is there another path for creative advertising?
News
The Daily Heller: Johnny Selman’s Stamps of Approval
Johnny Selman started Peace Post with his team at Selman in 2016 as a way to work on something meaningful between client projects. Led by its eponymous founder, the Brooklyn design studio otherwise specializes in… Read More »The Daily Heller: Johnny Selman’s Stamps of Approval
JinkoSolar to Report Second Quarter 2024 Results on August 30, 2024
SHANGRAO, China, Aug. 19, 2024 /PRNewswire/ — JinkoSolar Holding Co., Ltd. (“JinkoSolar” or the “Company”) (NYSE: JKS), one of the largest and most innovative solar module manufacturers in the world, today announced that it plans… Read More »JinkoSolar to Report Second Quarter 2024 Results on August 30, 2024
Heinz Launches Hum Hum: The Game-Changer at Esports World Cup
Research discovers that 90% of gamers struggle with snacking whilst playing. 75% of gamers dream to dip their snacks in their favorite sauces without having to pause their game. Heinz answered this call by… Read More »Heinz Launches Hum Hum: The Game-Changer at Esports World Cup
AMD to Significantly Expand Data Center AI Systems Capabilities with Acquisition of Hyperscale Solutions Provider ZT Systems
— Strategic acquisition to provide AMD with industry-leading systems expertise to accelerate deployment of optimized rack-scale solutions addressing $400 billion data center AI accelerator opportunity in 2027 — ZT Systems, a leading provider of AI… Read More »AMD to Significantly Expand Data Center AI Systems Capabilities with Acquisition of Hyperscale Solutions Provider ZT Systems
U.S. FDA Grants Tentative Approval of YUTREPIA™ (treprostinil) Inhalation Powder for Patients with Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD)
FDA confirmed that the amendment to add PH-ILD to the YUTREPIA NDA was proper and that application otherwise meets the requirements for approval under the Federal Food, Drug, and Cosmetic ActFinal Approval of YUTREPIA for… Read More »U.S. FDA Grants Tentative Approval of YUTREPIA™ (treprostinil) Inhalation Powder for Patients with Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD)